NEW YORK (GenomeWeb) – A pair of studies appearing in Nature Neuroscience yesterday uncovered epigenetic changes associated with the development of Alzheimer's disease.

For the studies, the two research teams conducted epigenome-wide association studies to search for DNA regions that were differentially methylated in people who had Alzheimer's disease as compared to those without the disease. While the researchers uncovered nearly a dozen differentially methylated regions, both groups homed in on a hypermethylated region at the ANK1 gene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.